Overlap of primary biliary cirrhosis and autoimmune hepatitis: Characteristics, therapy, and long term outcomes
Junko Yokokawa(National Institutes of Health), Hiromasa Ohira(Fukushima Medical University), Natsumi Sakamoto(Fujita Health University), Atsushi Takahashi(Fukushima Medical University), Hirohide Yokokawa(Fukushima Medical University), Fumiko Honma(Fukushima Medical University), Kyoko Monoe(Fukushima Medical University), Yukiko Kanno(Fukushima Medical University), Hironobu Saito(Fukushima Medical University), Kazumichi Abe(Fukushima Medical University)
Cited by 45
Related Papers
Combining a Recombinant Cancer Vaccine with Standard Definitive Radiotherapy in Patients with Localized Prostate Cancer
|Clinical Cancer Research|2005|371
Genome-wide Association Study Identifies TNFSF15 and POU2AF1 as Susceptibility Loci for Primary Biliary Cirrhosis in the Japanese Population
|The American Journal of Human Genetics|2012|272
The efficacy of ursodeoxycholic acid and bezafibrate combination therapy for primary biliary cirrhosis: A prospective, multicenter study
|Hepatology Research|2008|143
Endoscopic ultrasound-guided fine-needle aspiration of solid pancreatic masses with rapid on-site cytological evaluation by endosonographers without attendance of cytopathologists
|Journal of Gastroenterology|2009|132
Ito cell contraction in response to endothelin-1 and substance P
|Hepatology|1993|123